AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

MOXIFLOXACIN 400.000 Mg ;

16 registrations across 1 African market— 16 active

Markets with MOXIFLOXACIN 400.000 Mg ;

Recent registrations

Brand / ProductMarketHolderStatusExpires
QUINOMOXIN
Film Coated Tablets
🇪🇬EgyptAlfacure Pharmaceuticalsactive
Kinomoxi
Film Coated Tablets
🇪🇬EgyptAL ESRAA PHARMACEUTICAL OPTIMA-EGYPTactive
MOXILABACT
Film Coated Tablets
🇪🇬Egyptkahira pharmaceuticals and chemical industriesactive
AVALOX
Film Coated Tablets
🇪🇬EgyptBayer AGactive
MORTAPP
Film Coated Tablets
🇪🇬EgyptTrust pharmaceuticalactive
QUINOMOXIN
Film Coated Tablets
🇪🇬EgyptAlfacure Pharmaceuticalsactive
Meramerix
Film Coated Tablets
🇪🇬EgyptPharmed health careactive
Primoxizar
Film Coated Tablets
🇪🇬Egyptpharma cure pharmaceutical industriesactive
ACTIMOXIFLOX 400mg
Film Coated Tablets
🇪🇬EgyptMira International for Pharmaceuticals & Chemicalsactive
AVALOX
Film Coated Tablets
🇪🇬EgyptBayer AGactive
Fluroflox
Film Coated Tablets
🇪🇬EgyptTA PHARMAactive
MOXILABACT
Film Coated Tablets
🇪🇬Egyptkahira pharmaceuticals and chemical industriesactive
MORTAPP
Film Coated Tablets
🇪🇬EgyptTrust pharmaceuticalactive
MOXITRIX 400 mg f.c.tab
Film Coated Tablets
🇪🇬EgyptSpimaco Misr for pharmaceutical industriesactive
Primoxizar
Film Coated Tablets
🇪🇬Egyptpharma cure pharmaceutical industriesactive
Meramerix
Film Coated Tablets
🇪🇬EgyptPharmed health careactive

MOXIFLOXACIN 400.000 Mg ; in Africa — Regulatory Overview

MOXIFLOXACIN 400.000 Mg ; is registered across 1 African markets with 16 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Egypt. AfricaRegulatory refreshes this data daily from official government sources.

Of the 16 registrations, 16 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.